In spite of the extensive drives, days and dedication often required of them, many equine veterinarians couldn’t imagine doing anything other than taking care of horses in need.
Boehringer Ingelheim is celebrating these champions of equine health on World Veterinary Day today with a $10,000 donation to The Foundation for the Horse, the charitable arm of American Association of Equine Practitioners (AAEP), along with the release of an online video in their honor.
“Equine veterinarians are one-of-a-kind caregivers who put the health and welfare of the horse above everything else, including themselves,” says Renee Hall, head of the U.S. equine business of Boehringer Ingelheim. “We wanted to thank them for their passion and devotion both today and every day.”
The donation to The Foundation for the Horse will be used to help support the health and welfare of horses, including relevant research, education and outreach to the equine industry.
“Celebrating and supporting equine veterinarians through this gift will help us address key health concerns and needs facing the equine population and our veterinarians,” says David Foley, executive director of AAEP. “We are most appreciative of Boehringer Ingelheim’s continued support of the veterinarian and most importantly the horse through The Foundation.”
In addition, the video, which has been posted to the Boehringer Ingelheim Equine Health Facebook page and YouTube channel, features the daily challenges in the life of an equine veterinarian.
For example, as the video explains, “Your office doesn’t have walls. It has fences. And mud. And thunderstorms. And 1,200-pound patients that don’t like thunderstorms.”
“It’s a peek into the life of an equine veterinarian that all horse owners and lovers can appreciate,” says Hall. “It also brings to life why it’s so important to appreciate the commitment to care that equine veterinarians provide to their patients — both human and animal — every day.”
About Boehringer Ingelheim Animal Health
Boehringer Ingelheim is the second largest animal health business in the world, with net sales of $4.5 billion (4 billion euros) in 2019 and presence in more than 150 markets.
As the lives of animals and humans are intertwined, our 10,000 global employees are dedicated to enhancing the well-being of both – through science and innovation, as well as with their commitment and passion.
Respect for animals, people and the environment is at the heart of what we do. We develop medicines, services and innovative digital technologies to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society- threatening diseases.
Boehringer Ingelheim Animal Health has a significant presence in the United States, with more than 3,100 employees in places that include Georgia, Missouri, Iowa, Minnesota, New Jersey and Puerto Rico. To learn more, visit www.boehringeringelheim.us, www.facebook.com/BoehringerAHUS or www.twitter.com/Boehringer_AH.
About Boehringer Ingelheim
Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas: human pharmaceuticals, animal health and biopharmaceuticals. In 2018, Boehringer Ingelheim achieved net sales of around $20.7 billion (17.5 billion euros). R&D expenditure of about $3.8 billion (3.2 billion euros), corresponded to 18.1 per cent of net sales.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
PR Director, VMLY&R
Boehringer Ingelheim Animal Health – U.S. Communications